|Inception Date||October 26, 2012|
|Min. Initial Investment||$250.00|
|Voya U.S. Stock Index Portfolio||30.00|
|Voya Multi-Manager International Equity Fund||13.00|
|Voya Large Cap Value Fund||9.00|
|VY T. Rowe Price Growth Equity Portfolio||8.00|
|Voya Large-Cap Growth Fund||7.00|
|VY Invesco Comstock Portfolio||6.00|
|Voya Multi-Manager International Factors Fund||5.00|
|Voya MidCap Opportunities Fund||4.50|
|Voya Multi-Manager Mid Cap Value Fund||4.50|
|Voya Multi-Manager Emerging Markets Equity Fund||4.00|
|Voya Global Bond Fund||3.00|
|Voya High Yield Bond Fund||2.00|
|Voya Small Cap Growth Fund||2.00|
|VY Columbia Small Cap Value II Portfolio||2.00|
Contributions to this individual Investment Option will be invested solely in the corresponding mutual fund. Before making contributions to this Investment Option, you should consider the more detailed information about the underlying mutual fund in which it invests, including its investment objectives and policies, risks, and expenses, contained in the links below. The information contained in the mutual fund profile page is only for the corresponding mutual fund. The profile pages will describe the underlying mutual fund the 529 Investment Option is investing in, not the Tomorrow’s Scholar 529 Investment Option. Participants in a Tomorrow’s Scholar 529 Investment Option are advised that they do not own shares of the underlying mutual fund directly, but rather own shares of an Investment Option in the Tomorrow’s Scholar 529 Plan. As such, performance information for the corresponding underlying mutual fund does not reflect the imposition of the sales charges or other fees and expenses that the Tomorrow’s Scholar 529 Plan imposes. For information regarding the expenses of a particular Tomorrow’s Scholar 529 Investment Option, including sales charges, the program management fee, state administrative fee and other fees, please review the Program Description Booklet with your financial advisor.
Average Annual Total Returns %
As of February 28, 2023
As of December 31, 2022
|Most Recent Month End||YTD||1 YR||3 YR||5 YR||10 YR||Expense Ratios|
|Net Asset Value||+4.26||-8.89||+7.57||+5.30||+7.45||1.07%||1.03%|
|With Sales Charge||+0.59||-12.09||+5.84||+4.27||+6.92|
|Net Asset Value||-19.14||-19.14||+2.98||+4.52||+7.44||1.07%||1.03%|
|With Sales Charge||-21.97||-21.97||+1.33||+3.51||+6.92|
|Voya WI 529 Aggressive Growth Composite Index||+4.34||-7.09||+9.09||+6.65||+8.72||—||—|
|Voya WI 529 Aggressive Growth Composite Index||-17.41||-17.41||+4.34||+5.92||+8.79||—||—|
Inception Date - Class A:October 26, 2012
Current Maximum Sales Charge: 3.50%
The performance quoted represents past performance and does not guarantee future results. Current performance may be lower or higher than the performance information shown. The investment return and principal value of an investment in the Portfolio will fluctuate, so that your shares, when redeemed, may be worth more or less than their original cost. See above "Average Annual Total Returns %" for performance information current to the most recent month-end.
Returns for the other share classes will vary due to different charges and expenses. Performance assumes reinvestment of distributions and does not account for taxes.
Total investment return at net asset value has been calculated assuming a purchase at net asset value at the beginning of the period and a sale at net asset value at the end of the period; and assumes reinvestment of dividends, capital gain distributions and return of capital distributions/allocations, if any, in accordance with the provisions of the dividend reinvestment plan. Net asset value equals total Fund assets net of Fund expenses such as operating costs and management fees. Total investment return at net asset value is not annualized for periods less than one year.
The net expense ratio is the result of a voluntary 0.04% waiver of the Board Fee effective through 2022-12-31. If the waiver is not continued thereafter, the Board Fee would be 0.10% of the average net assets of each Investment Option.
Past performance does not guarantee future results.